Effect of central administration of the κ-opiate receptor agonist U 69.593 on neurohypophyseal hormone levels in blood and cerebrospinal fluid

Neuropeptides

Volumn 30, Issue 5, 1996, Pages 452-455

  Van Wimersma Greidanus, Tj B ^a   Janssen, S ^a   Frankhuijzen Sierevogel, J C ^a   Maigret, C ^a   Van De Heijning, B J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

KAPPA OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE AGONIST; OXYTOCIN; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; HORMONE BLOOD LEVEL; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NEUROHYPOPHYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0029998537     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(96)90009-8     Document Type: Article

References (29)

1. Maysinger D. Opioids and hypophysis. Acta Pharm Jugosl 1985; 35: 1-14.
2. Millan MJ, Herz A. The endocrinology of the opioids. Int Rev Neurobiol 1985; 26: 1-83.
3. Van Wimersma Greidanus TB, Grossman AB. Opioid regulation of pituitary function. In: Progress in sensory physiology. Berlin: Springer-Verlag, 1991: 1-64.
4. Dogterom J, Van Wimersma Greidanus TjB, De Wied D. Vasopressin in cerebrospinal fluid and plasma of man, dog, and rat. Am J Physiol 1978; 234: E463-E467
5. Robinson ICAF. Neurohypophysial peptides in cerebrospinal fluid. Prog Brain Res 1983; 60: 129-145.
6. Robinson ICAF, Coombes JE. Neurohypophysial peptides in cerebrospinal fluid: An update. Ann NY Acad Sci 1993; 689: 269-283.
7. Rodriguez EM. The cerebrospinal fluid as a pathway in neuroendocrine integration. J Endocrinol 1976; 71: 407-443.
8. Mens WBJ. Presence and significance of neurohypophyseal hormones in cerebrospinal fluid. Exp Clin Endocrinol 1987; 6: 185-188.
9. Mens WBJ, Bouman HJ, Bakker EAD, Van Wimersma Greidanus TjB. Differential effects of various stimuli on AVP levels in blood and cerebrospinal fluid. Eur J Pharmacol 1980; 68: 89-92.
10. Mens WBJ, Van Dam AF, Van Egmond MAH, Bakker EAD, Legros JJ, Van Wimersma Greidanus TjB. Neurohypophyseal hormones in cerebrospinal fluid. Front Horm Res 1982; 9: 119-130.
11. Szczepanska-Sadowska E, Simon-Oppermann C, Gray D, Simon E. Control of central release of vasopressin. J Physiol 1984; 79: 432-439.
12. Ten Haaf JA, Van Wimersma Greidanus TjB, Maigret C, De Wied D. Effect of the opioid peptide beta-endorphin on the in vivo release of vasopressin in rats under various conditions. Neuroendocrinology 1986; 44: 102-107
13. Ten Haaf JA, Maigret C, Andringa-Bakker EAD, Van Wimersma Greidanus TjB. Dynorphin-(1-13) is a potent in vivo suppressor of vasopressin levels in the rat. Acta Endocrinologica 1987; 96-101.
14. Van de Heijning BJM, Koekkoek-Van den Herik I, Van Wimersma Greidanus TjB. The opioid receptor subtypes μ and K, but not δ, are involved in the control of the vasopressin and oxytocin release in the rat. Eur J Pharmacol 1991; 209: 199-206.
15. Van Wimersma Greidanus TjB, Maigret C, Frankhuijzen-Sierevogel CJ. Effects of opioid peptides on oxytocin release into cerebrospinal fluid and peripheral circulation in rats. 75th Ann. Meeting Endocrine Society, Las Vegas, USA, 1993; nr. 189B.
16. Van Wimersma Greidanus TjB, Maigret C, Frankhuijzen-Sierevogel CJ, Van de Heijning BJM. Effects of opioid peptides on neurohypophyseal hormone release into cerebrospinal fluid and peripheral circulation in rats. Eur J Endocrinol 1994; 130 suppl. 2: P3. 134.
17. Van de Heijning BJM, Van Wimersma Greidanus TjB. The effect on neurohypophyseal hormone release, diuresis and electrolyte output of μ- and κ-opioid agonists. Neurosci Res Commun 1994; 15: 11-19.
18. Carter DA, Lightman SL. Inhibition of vasopressin secretion by a κ-opiate receptor agonist. Neuroendocrinol Lett 1984; 6: 95-100.
19. Van de Heijning BJM, Koekkoek-Van den Herik I, Ivanyi T, Van Wimersma Greidanus TjB.Solid-phase extraction of plasma vasopressin: evaluation, validation and application. J Chromatogr 1991; 565: 159-171.
20. Ten Haaf JA, Terwel D, Van de Heijning BJM, Van Wimersma Greidanus TjB. Radioimmunoassay, a goal or a tool? The setup of a reliable, fast, and cheap radioimmunoassay for vasopressin in biological samples. J Controlled Release 1992; 21: 23-36.
21. Higuchi T, Honda K, Fukuoka T, Negoro H, Wakabayashi K. Release of oxytocin during suckling and parturition in the rat. J Endocrinol 1985; 105: 339-346.
22. Neumann I, Ludwig M, Engelmann M, Pittman QJ, Landgraf R. Simultaneous microdialysis in blood and brain: Oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat. Neuroendocrinology 1993; 58: 637-645.
23. Ludwig M, Callahan MF, Neumann I, Landgraf R, Morris M. Systemic osmotic stimulation increases vasopressin and oxytocin release within the supraoptic nucleus. J Neuroendocrinol 1994; 6: 369-373.
24. Barnard RR, Morris M. Cerebrospinal fluid vasopressin and oxytocin: Evidence for an osmotic response. Neurosci Lett 1982; 29: 275-279.
25. Jolkkonen J, Tuomisto L, Van Wimersma Greidanus TjB, Läärä E, Riekkinen P. Effects of osmotic stimuli on vasopressin levels in the CSF of rats. Peptides 1988; 9: 109-111.
26. Doris PA, Bell FR. Vasopressin in plasma and cerebrospinal fluid of hydrated and dehydrated steers. Neuroendocrinology 1984; 38: 290-296.
27. Amico JA, Challinor SM, Cameron JL Pattern of oxytocin concentrations in the plasma and cerebrospinal fluid of lactating Rhesus monkeys (Macaca mulatta): Evidence for functionally independent oxytocinergic pathways in primates. J Clin Endocrinol Metab 1990; 71: 1531-1535.
28. Sørensen PS. Studies of vasopressin in the human cerebrospinal fluid. Acta Neurol Scand 1986; 74: 81-102.
29. Landgraf R, Günther O. Vasopressin and oxytocin in cerebrospinal fluid and plasma of conscious rabbits - response to dehydration and haemorrhage. Biomed Biochim Acta 1983; 42: 1339-1341.